Case number 1:23-cv-01332
AbbVie Inc. v. Hetero USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 3, 2024 | 76 | NOTICE of Appearance by Renee Mosley Delcollo on behalf of Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc. (Delcollo, Renee) (Entered: 07/03/2024) (1) |
| Jul 2, 2024 | N/A | ORAL ORDER - Pursuant to the Scheduling Order, the parties contacted Chambers to request a teleconference for protective order disputes, IT IS HEREBY ORDERED that a Protective Order Dispute Hearing is set for 7/16/2024 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. The Court will not accept any submissions in advance of this hearing. (dlw) (Entered: 07/02/2024) (0) |
| Jun 28, 2024 | 75 | NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions (Sun) filed by AbbVie Inc. (Tigan, Jeremy) Modified on 6/28/2024 (dlw). (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 74 | NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions (Sandoz) filed by AbbVie Inc. (Tigan, Jeremy) Modified on 6/28/2024 (dlw). (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 73 | NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions (Hetero Defendants) filed by AbbVie Inc. (Tigan, Jeremy) Modified on 6/28/2024 (dlw). (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 72 | NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions (Aurobindo Defendants) filed by AbbVie Inc. (Tigan, Jeremy) Modified on 6/28/2024 (dlw). (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 71 | NOTICE OF SERVICE of (1) Plaintiff's First Set of Interrogatories to Sun Pharmaceutical Industries, Ltd. (Nos. 1-12); and (2) Plaintiff's First Set of Requests to Sun Pharmaceutical Industries, Ltd. for the Production of Documents and Things (Nos. 1-102) filed by AbbVie Inc..(Tigan, Jeremy) (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 70 | NOTICE OF SERVICE of (1) Plaintiff's First Set of Interrogatories to Sandoz Inc. (Nos. 1-12); and (2) Plaintiff's First Set of Requests to Sandoz Inc. for the Production of Documents and Things (Nos. 1-102) filed by AbbVie Inc..(Tigan, Jeremy) (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 69 | NOTICE OF SERVICE of (1) Plaintiff's First Set of Interrogatories to Hetero (Nos. 1-12); and (2) Plaintiff's First Set of Requests to Hetero for the Production of Documents and Things (Nos. 1-102) filed by AbbVie Inc..(Tigan, Jeremy) (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 68 | NOTICE OF SERVICE of (1) Plaintiff's First Set of Interrogatories to Aurobindo (Nos. 1-12); and (2) Plaintiff's First Set of Requests to Aurobindo for the Production of Documents and Things (Nos. 1-103) filed by AbbVie Inc..(Tigan, Jeremy) (Entered: 06/28/2024) (3) |
| Jun 20, 2024 | N/A | SO ORDERED re 67 STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to June 24, 2024. ORDERED by Judge Maryellen Noreika on 6/20/2024. (dlw) (Entered: 06/20/2024) (0) |
| Jun 18, 2024 | 67 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to June 24, 2024 - filed by AbbVie Inc.. (Tigan, Jeremy) (Entered: 06/18/2024) (2) |
| Jun 18, 2024 | N/A | SO ORDERED re 66 STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to June 18, 2024. ORDERED by Judge Maryellen Noreika on 6/18/2024. (dlw) (Entered: 06/18/2024) (0) |
| Jun 17, 2024 | 66 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to June 18, 2024 - filed by AbbVie Inc.. (Tigan, Jeremy) (Entered: 06/17/2024) (2) |
| Jun 2, 2024 | 65 | Official Transcript of Scheduling Telephone Conference held on 05/09/2024 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 6/24/2024. Redacted Transcript Deadline set for 7/3/2024. Release of Transcript Restriction set for 9/3/2024. (dh) (Entered: 06/02/2024) (0) |
| May 28, 2024 | 64 | SO ORDERED re 63 Stipulation of Dismissal. Party Intas Pharmaceuticals Ltd. and Accord Healthcare, Inc. terminated. Attorney Julie A. Vernon; Joel M. Wallace; Matthew T. Wilkerson; Kenneth Laurence Dorsney and Sailesh K. Patel terminated as to these Defendants. Signed by Judge Maryellen Noreika on 5/28/2024. (dlw) (Entered: 05/28/2024) (4) |
| May 24, 2024 | 63 | STIPULATION of Dismissal (Between Plaintiff and Defendants Intas Pharmaceuticals Ltd. and Accord Healthcare, Inc.) by AbbVie Inc. (Tigan, Jeremy) Modified on 5/28/2024 (dlw). (Entered: 05/24/2024) (4) |
| May 22, 2024 | 62 | NOTICE OF SERVICE of Defendant, Sun Pharmaceutical Industries Ltd.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Sun Pharmaceutical Industries, Ltd..(Myer, R.) (Entered: 05/22/2024) (2) |
| May 21, 2024 | 61 | NOTICE OF SERVICE of Defendants Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc..(Schladweiler, Benjamin) (Entered: 05/21/2024) (3) |
| May 21, 2024 | 60 | NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Rule 26(a)(1) filed by AbbVie Inc..(Tigan, Jeremy) (Entered: 05/21/2024) (7) |
| May 20, 2024 | 59 | NOTICE OF SERVICE of (i) Sandoz Inc.'s Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery; and, (ii) Defendant Sandoz Inc.'s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 05/20/2024) (2) |
| May 17, 2024 | 58 | NOTICE OF SERVICE of Defendant, Sun Pharmaceutical Industries Ltd.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Sun Pharmaceutical Industries, Ltd..(Myer, R.) (Entered: 05/17/2024) (2) |
| May 16, 2024 | 57 | SCHEDULING ORDER: Joinder of Parties due by 12/18/2024. Amended Pleadings due by 12/18/2024. Fact Discovery completed by 3/12/2025. Opening Expert Reports due by 10/7/2025. Rebuttal Expert Reports due by 12/12/2025. Reply Expert Reports due by 1/27/2026. Expert Discovery due by 4/7/2026. Claim Construction Opening Brief served by 4/9/2025. Claim Construction Answering Brief served by 5/14/2025. Claim Construction Reply Brief served by 6/11/2025. Claim Construction Surreply Brief served by 7/2/2024. Joint Claim Construction Brief filed by 7/16/2025. A Markman Hearing is set for 8/6/2025 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 7/20/2026 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 7/27/2026 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 5/16/2024. (dlw) (Entered: 05/16/2024) (13) |
| May 15, 2024 | 56 | Joint PROPOSED ORDER -- [Proposed] Scheduling Order -- by AbbVie Inc.. (Blumenfeld, Jack) (Entered: 05/15/2024) (13) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Kevin J. DeJong for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 05/14/2024) (0) |
| May 13, 2024 | 55 | NOTICE OF SERVICE of (1) Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.'s Core Technical Documents and; (2) Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.'s 26(a)(1) and Paragraph 3 Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) (Entered: 05/13/2024) (3) |
| May 13, 2024 | 54 | NOTICE OF SERVICE of (1) Intas Pharmaceuticals Ltd. and Accord Healthcare, Inc.'s Core Technical Documents and; (2) Intas Pharmaceuticals Ltd. and Accord Healthcare Inc.'s 26(a)(1) and Paragraph 3 Disclosures filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd..(Dorsney, Kenneth) (Entered: 05/13/2024) (3) |
| May 10, 2024 | 53 | NOTICE OF SERVICE of Defendants Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA, Inc.'s (1) Production of core technical documents (Bates range HETEROUPA_000001 - HETEROUPA_023183) and (2) Initial Disclosures Pursuant to Delaware's Default Standard for Discovery of Electronically Stored Information filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc..(Schladweiler, Benjamin) (Entered: 05/10/2024) (2) |
| May 10, 2024 | 52 | NOTICE OF SERVICE of Defendant, Sun Pharmaceutical Industries Ltd.'s Core Technical Documents pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery filed by Sun Pharmaceutical Industries, Ltd..(Myer, R.) (Entered: 05/10/2024) (2) |
| May 10, 2024 | 51 | NOTICE OF SERVICE of Sandoz Inc.'s Core Technical Documents bearing bates numbers SDZUPAD00037231 through SDZUPAD00041163 [HIGHLY CONFIDENTIAL ATTORNEYS EYES ONLY] pursuant to Local Rule 26.2 filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 05/10/2024) (2) |
| May 10, 2024 | 50 | NOTICE OF SERVICE of (i) Sandoz Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery; and, (ii) Sandoz Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 05/10/2024) (2) |
| May 10, 2024 | 49 | NOTICE OF SERVICE of Plaintiff's Initial Paragraph 3 Disclosures filed by AbbVie Inc..(Blumenfeld, Jack) (Entered: 05/10/2024) (7) |
| May 10, 2024 | N/A | Pro Hac Vice Attorney Jonathan R Wise for Hetero Labs Limited, Hetero Labs Limited Unit-V,and Hetero USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/10/2024) (0) |
| May 9, 2024 | N/A | Minute Entry for proceedings held before Judge Maryellen Noreika - Scheduling Telephone Conference held on 5/9/2024 re Proposed Scheduling Order ( 45 ). The Court adopts the plaintiff's proposal regarding paragraph 7. The parties shall submit a revised proposed scheduling order within one week. (Court Reporter Dale Hawkins.) (mdb) (Entered: 05/09/2024) (0) |
| May 1, 2024 | 48 | ORAL ORDER Setting TELEPHONIC Scheduling Conference - IT IS HEREBY ORDERED that a telephonic Scheduling Conference is set for 5/9/2024 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator (diana_welham@ded.uscourts.gov). ORDERED by Judge Maryellen Noreika on 5/1/2024. (dlw) (Entered: 05/01/2024) (0) |
| Apr 24, 2024 | N/A | SO ORDERED re 46 MOTION for Pro Hac Vice Appearance of Attorney David P. Frazier and Yi Sun. Ordered by Judge Maryellen Noreika on 4/24/2024. (as) (Entered: 04/24/2024) (0) |
| Apr 24, 2024 | 47 | Pro Hac Vice Fee - Credit Card Payment received for David P. Frazier and Yi Sun. ( re 46 MOTION for Pro Hac Vice Appearance of Attorney David P. Frazier and Yi Sun )( Payment of $ 100, receipt number ADEDC-4392074).(Blumenfeld, Jack) (Entered: 04/24/2024) (0) |
| Apr 24, 2024 | 46 | MOTION for Pro Hac Vice Appearance of Attorney David P. Frazier and Yi Sun - filed by AbbVie Inc.. (Blumenfeld, Jack) (Entered: 04/24/2024) (7) |
| Apr 19, 2024 | 45 | PROPOSED ORDER -- [Proposed] Scheduling Order by AbbVie Inc. (Attachments: # 1 Cover Letter to The Honorable Maryellen Noreika)(Tigan, Jeremy) Modified on 4/19/2024 (dlw). (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 44 | NOTICE OF SERVICE of Plaintiff's Initial Disclosures Identifying Defendants' Accused Products and Plaintiff's Asserted Patents filed by AbbVie Inc..(Tigan, Jeremy) (Entered: 04/19/2024) (6) |
| Apr 5, 2024 | N/A | Pro Hac Vice Attorney Matthew T. Wilkerson for Accord Healthcare, Inc., Aurobindo Pharma Ltd., Pharma USA, Inc., and Intas Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 04/05/2024) (0) |
| Apr 5, 2024 | N/A | Pro Hac Vice Attorneys Joel M. Wallace, Sailesh K. Patel, and Julie A. Vernon for Accord Healthcare, Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., and Intas Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 04/05/2024) (0) |
| Apr 4, 2024 | N/A | SO ORDERED re 42 MOTION for Pro Hac Vice Appearance of Attorney Matthew T. Wilkerson filed by Aurobindo Pharma USA, Inc., Intas Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Accord Healthcare, Inc. ORDERED by Judge Maryellen Noreika on 4/4/2024. (dlw) (Entered: 04/04/2024) (0) |
| Apr 4, 2024 | 43 | Pro Hac Vice Fee - Credit Card Payment received for Matthew T. Wilkerson. ( re 42 MOTION for Pro Hac Vice Appearance of Attorney Matthew T. Wilkerson )( Payment of $ 50, receipt number ADEDC-4377307).(Dorsney, Kenneth) (Entered: 04/04/2024) (0) |
| Apr 4, 2024 | 42 | MOTION for Pro Hac Vice Appearance of Attorney Matthew T. Wilkerson - filed by Accord Healthcare, Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Intas Pharmaceuticals Ltd.. (Dorsney, Kenneth) (Entered: 04/04/2024) (3) |
| Mar 20, 2024 | 41 | ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. A 5-day bench trial will be set for 7/27/2026. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiff serves its opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 3/20/2024. (dlw) (Entered: 03/20/2024) (0) |
| Mar 20, 2024 | 40 | ANSWER to 32 Answer to Complaint, Counterclaim [Plaintiff's Answer to Hetero's Counterclaims] by AbbVie Inc. (Tigan, Jeremy) Modified on 3/20/2024 (dlw). (Entered: 03/20/2024) (30) |
| Mar 19, 2024 | 39 | ANSWER to 30 Answer to Complaint, Counterclaims [Plaintiff's Answer to Aurobindo's Counterclaims] by AbbVie Inc..(Tigan, Jeremy) Modified on 3/19/2024 (mdb). (Entered: 03/19/2024) (30) |
| Mar 19, 2024 | 38 | ANSWER to 28 Answer to Complaint, Counterclaims [Plaintiff's Answer to Intas's Counterclaims] by AbbVie Inc..(Tigan, Jeremy) Modified on 3/19/2024 (mdb). (Entered: 03/19/2024) (30) |
| Mar 11, 2024 | 37 | Pro Hac Vice Fee - Credit Card Payment received for Sailesh K. Patel, Julie A. Vernon, and Joel M. Wallace. ( re 36 MOTION for Pro Hac Vice Appearance of Attorney Sailesh K. Patel, Attorney Julie A. Vernon, and Attorney Joel M. Wallace )( Payment of $ 150, receipt number ADEDC-4357865).(Dorsney, Kenneth) (Entered: 03/11/2024) (0) |
| Mar 11, 2024 | N/A | SO ORDERED re 36 MOTION for Pro Hac Vice Appearance of Attorney Sailesh K. Patel, Attorney Julie A. Vernon, and Attorney Joel M. Wallace filed by Aurobindo Pharma USA, Inc., Intas Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Accord Healthcare, Inc. ORDERED by Judge Maryellen Noreika on 3/11/2024. (dlw) (Entered: 03/11/2024) (0) |
| Mar 11, 2024 | 36 | MOTION for Pro Hac Vice Appearance of Attorney Sailesh K. Patel, Attorney Julie A. Vernon, and Attorney Joel M. Wallace - filed by Accord Healthcare, Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Intas Pharmaceuticals Ltd.. (Dorsney, Kenneth) (Entered: 03/11/2024) (5) |
| Feb 29, 2024 | N/A | Pro Hac Vice Attorneys Timothy H. Kratz,Michael P. Hogan, and George J. Barry, III for Sun Pharmaceutical Industries, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/29/2024) (0) |
| Feb 29, 2024 | N/A | SO ORDERED re 34 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry, III, and Michael P. Hogan filed by Sun Pharmaceutical Industries, Ltd. ORDERED by Judge Maryellen Noreika on 2/29/2024. (dlw) (Entered: 02/29/2024) (0) |
| Feb 29, 2024 | 35 | Pro Hac Vice Fee - Credit Card Payment received for Timothy H. Kratz, George J. Barry, III, and Michael P. Hogan. ( re 34 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry, III, and Michael P. Hogan )( Payment of $ 150, receipt number ADEDC-4350670).(Myer, R.) (Entered: 02/29/2024) (0) |
| Feb 29, 2024 | 34 | MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry, III, and Michael P. Hogan - filed by Sun Pharmaceutical Industries, Ltd.. (Myer, R.) (Entered: 02/29/2024) (4) |
| Feb 28, 2024 | 33 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Drugs Limited, Corporate Parent Hetero Labs Limited for Hetero USA, Inc. filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc.. (Schladweiler, Benjamin) (Entered: 02/28/2024) (2) |
| Feb 28, 2024 | 32 | ANSWER to 1 Complaint, Affirmative Defenses and, COUNTERCLAIM against AbbVie Inc. by Hetero Labs Limited Unit-V, Hetero USA, Inc., Hetero Labs Limited. (Schladweiler, Benjamin) Modified on 2/28/2024 (dlw). (Entered: 02/28/2024) (30) |
| Feb 27, 2024 | 31 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) (Entered: 02/27/2024) (2) |
| Feb 27, 2024 | 30 | ANSWER to 1 Complaint,, , COUNTERCLAIM against All Plaintiffs by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd..(Dorsney, Kenneth) (Entered: 02/27/2024) (30) |
| Feb 27, 2024 | 29 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Intas Pharmaceuticals Limited for Accord Healthcare, Inc. filed by Accord Healthcare, Inc., Intas Pharmaceuticals Ltd.. (Dorsney, Kenneth) (Entered: 02/27/2024) (2) |
| Feb 27, 2024 | 28 | ANSWER to 1 Complaint,, , COUNTERCLAIM against All Plaintiffs by Intas Pharmaceuticals Ltd., Accord Healthcare, Inc..(Dorsney, Kenneth) (Entered: 02/27/2024) (30) |
| Feb 27, 2024 | 27 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sun Pharmaceutical Industries, Ltd.. (Myer, R.) (Entered: 02/27/2024) (2) |
| Feb 27, 2024 | 26 | ANSWER to 1 Complaint,, by Sun Pharmaceutical Industries, Ltd..(Myer, R.) (Entered: 02/27/2024) (30) |
| Feb 26, 2024 | 25 | ANSWER to 23 Answer to Complaint, Sandoz's Counterclaims by AbbVie Inc. (Blumenfeld, Jack) Modified on 2/27/2024 (dlw). (Entered: 02/26/2024) (30) |
| Feb 8, 2024 | N/A | Pro Hac Vice Attorney Kristin M. Beale for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/08/2024) (0) |
| Feb 5, 2024 | 24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sandoz AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 02/05/2024) (2) |
| Feb 5, 2024 | 23 | ANSWER to 1 Complaint, COUNTERCLAIM against All Plaintiffs by Sandoz Inc. (Gattuso, Dominick) Modified on 2/6/2024 (dlw). (Entered: 02/05/2024) (30) |
| Feb 5, 2024 | N/A | Pro Hac Vice Attorney Emily L. Rapalino for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/05/2024) (0) |
| Jan 31, 2024 | N/A | Pro Hac Vice Attorney Daryl L. Wiesen for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/31/2024) (0) |
| Jan 30, 2024 | N/A | Pro Hac Vice Attorney Thomas V. McTigue, IV for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 01/30/2024) (0) |
| Jan 30, 2024 | N/A | SO ORDERED re 21 MOTION for Pro Hac Vice Appearance of Attorney Emily L. Rapalino, Daryl L. Wiesen, Kevin J. DeJong, Kristin M. Beale, Ph.D., and Thomas V. McTigue IV of Goodwin Procter LLP filed by Sandoz Inc. ORDERED by Judge Maryellen Noreika on 1/30/2024. (dlw) (Entered: 01/30/2024) (0) |
| Jan 30, 2024 | 22 | Pro Hac Vice Fee - Credit Card Payment received for Emily L. Rapalino, Daryl L. Wiesen, Kevin J. DeJong, Kristin M. Beale, Ph.D., and Thomas V. McTigue IV. ( re 21 MOTION for Pro Hac Vice Appearance of Attorney Emily L. Rapalino, Daryl L. Wiesen, Kevin J. DeJong, Kristin M. Beale, Ph.D., and Thomas V. McTigue IV of Goodwin Procter LLP )( Payment of $ 250, receipt number ADEDC-4325985).(Gattuso, Dominick) (Entered: 01/30/2024) (0) |
| Jan 30, 2024 | 21 | MOTION for Pro Hac Vice Appearance of Attorney Emily L. Rapalino, Daryl L. Wiesen, Kevin J. DeJong, Kristin M. Beale, Ph.D., and Thomas V. McTigue IV of Goodwin Procter LLP - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 01/30/2024) (7) |
| Jan 29, 2024 | N/A | SO ORDERED re 20 STIPULATION TO EXTEND TIME for Aurobindo USA, Inc. and Accord Healthcare, Inc. to answer, move or otherwise respond to the Complaint to February 28, 2024 (Set/Reset Answer Deadlines: Accord Healthcare, Inc. answer due 2/28/2024; Aurobindo Pharma USA, Inc. answer due 2/28/2024). ORDERED by Judge Maryellen Noreika on 1/29/2024. (dlw) (Entered: 01/29/2024) (0) |
| Jan 26, 2024 | 20 | STIPULATION TO EXTEND TIME for Aurobindo USA, Inc. and Accord Healthcare, Inc. to answer, move or otherwise respond to the Complaint to February 28, 2024 - filed by Accord Healthcare, Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Intas Pharmaceuticals Ltd.. (Dorsney, Kenneth) (Entered: 01/26/2024) (2) |
| Jan 18, 2024 | N/A | SO ORDERED re 19 STIPULATION TO EXTEND TIME for Defendant Hetero USA, Inc. to move, answer, or otherwise respond to AbbVie's Complaint to February 28, 2024 (Set/Reset Answer Deadlines: Hetero USA, Inc. answer due 2/28/2024). ORDERED by Judge Maryellen Noreika on 1/18/2024. (dlw) (Entered: 01/18/2024) (0) |
| Jan 18, 2024 | 19 | STIPULATION TO EXTEND TIME for Defendant Hetero USA, Inc. to move, answer, or otherwise respond to AbbVie's Complaint to February 28, 2024 - filed by Hetero USA, Inc.. (Schladweiler, Benjamin) (Entered: 01/18/2024) (2) |
| Jan 2, 2024 | 18 | SO ORDERED re 17 Stipulation and Order Dismissing Defendants Sandoz Private Limited and Sandoz GmbH without Prejudice and Amending Caption to Reflect Same. Party Sandoz GmbH and Sandoz Private Limited terminated. Attorney Dominick T. Gattuso terminated as to these Defendants. Signed by Judge Maryellen Noreika on 1/2/2024. (dlw) (Entered: 01/02/2024) (5) |
| Dec 22, 2023 | 17 | STIPULATION of Dismissal of Defendants Sandoz Private Limited and Sandoz GmbH Without Prejudice and Amending Caption to Reflect Same by AbbVie Inc. (Tigan, Jeremy) Modified on 1/2/2024 (dlw). (Entered: 12/22/2023) (5) |
| Dec 13, 2023 | N/A | Pro Hac Vice Attorneys Giancarlo Scaccia and Kathryn E. Albanese for Hetero Labs Limited, Hetero Labs Limited Unit-V, and Hetero USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 12/13/2023) (0) |
| Dec 11, 2023 | N/A | SO ORDERED re 16 MOTION for Pro Hac Vice Appearance of Attorney Scott J. Bornstein, Jonathan R. Wise, Giancarlo L. Scaccia and Kathryn E. Albanese filed by Hetero Labs Limited Unit-V, Hetero Labs Limited, Hetero USA, Inc. ORDERED by Judge Maryellen Noreika on 12/11/2023. (dlw) (Entered: 12/11/2023) (0) |
| Dec 11, 2023 | 16 | MOTION for Pro Hac Vice Appearance of Attorney Scott J. Bornstein, Jonathan R. Wise, Giancarlo L. Scaccia and Kathryn E. Albanese - filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc. (Attachments: # 1 Certification of Scott J. Bornstein, # 2 Certification of Jonathan R. Wise, # 3 Certification of Giancarlo L. Scaccia, # 4 Certification of Kathryn E. Albanese)(Schladweiler, Benjamin) Modified on 12/11/2023 (dlw). (Entered: 12/11/2023) (0) |
| Dec 8, 2023 | 15 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Hetero Labs Limited Unit-V waiver sent on 11/30/2023, answer due 2/28/2024. (Tigan, Jeremy) (Entered: 12/08/2023) (1) |
| Dec 8, 2023 | 14 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Hetero Labs Limited waiver sent on 11/30/2023, answer due 2/28/2024. (Tigan, Jeremy) (Entered: 12/08/2023) (1) |
| Dec 8, 2023 | 13 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Hetero USA, Inc. waiver sent on 11/30/2023, answer due 1/29/2024. (Tigan, Jeremy) (Entered: 12/08/2023) (1) |
| Dec 5, 2023 | 12 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Intas Pharmaceuticals Ltd. waiver sent on 11/30/2023, answer due 2/28/2024. (Tigan, Jeremy) (Entered: 12/05/2023) (1) |
| Dec 5, 2023 | 11 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Aurobindo Pharma Ltd. waiver sent on 11/30/2023, answer due 2/28/2024. (Tigan, Jeremy) (Entered: 12/05/2023) (1) |
| Dec 5, 2023 | 10 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Aurobindo Pharma USA, Inc. waiver sent on 11/30/2023, answer due 1/29/2024. (Tigan, Jeremy) (Entered: 12/05/2023) (1) |
| Dec 5, 2023 | 9 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Accord Healthcare, Inc. waiver sent on 11/30/2023, answer due 1/29/2024. (Tigan, Jeremy) (Entered: 12/05/2023) (1) |
| Dec 1, 2023 | 8 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Sun Pharmaceutical Industries, Ltd. waiver sent on 11/29/2023, answer due 2/27/2024. (Tigan, Jeremy) (Entered: 12/01/2023) (1) |
| Dec 1, 2023 | N/A | SO ORDERED, re 7 MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, Nicholas L. Evoy and Megan L. Hare filed by AbbVie Inc. Ordered by Judge Maryellen Noreika on 12/1/2023. (as) (Entered: 12/01/2023) (0) |
| Dec 1, 2023 | 7 | MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, Nicholas L. Evoy and Megan L. Hare - filed by AbbVie Inc.. (Tigan, Jeremy) (Entered: 12/01/2023) (7) |
| Nov 22, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 11/22/2023) (0) |
| Nov 20, 2023 | 6 | Summons Issued as to Accord Healthcare, Inc. on 11/20/2023; Aurobindo Pharma Ltd. on 11/20/2023; Aurobindo Pharma USA, Inc. on 11/20/2023; Hetero Labs Limited on 11/20/2023; Hetero Labs Limited Unit-V on 11/20/2023; Hetero USA, Inc. on 11/20/2023; Intas Pharmaceuticals Ltd. on 11/20/2023; Sandoz GmbH on 11/20/2023; Sandoz Inc. on 11/20/2023; Sandoz Private Limited on 11/20/2023; Sun Pharmaceutical Industries, Ltd. on 11/20/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued, # 3 Summons Issued, # 4 Summons Issued, # 5 Summons Issued, # 6 Summons Issued, # 7 Summons Issued, # 8 Summons Issued, # 9 Summons Issued, # 10 Summons Issued)(mpb) (Entered: 11/21/2023) (0) |
| Nov 20, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (mpb) (Entered: 11/21/2023) (1) |
| Nov 20, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (mpb) (Entered: 11/21/2023) (3) |
| Nov 20, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/10/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/16/2027. (mpb) (Entered: 11/21/2023) (2) |
| Nov 20, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 11/21/2023) (3) |
| Nov 20, 2023 | 1 | COMPLAINT filed against Accord Healthcare, Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc., Intas Pharmaceuticals Ltd., Sandoz GmbH, Sandoz Inc., Sandoz Private Limited, Sun Pharmaceutical Industries, Ltd. ( Filing fee $ 402, receipt number ADEDC-4277872.) - filed by AbbVie Inc.. (Attachments: # 1 Exhibit A-B, # 2 Exhibit C-E, # 3 Exhibit F-J, # 4 Exhibit K, # 5 Exhibit L, # 6 Exhibit M-O, # 7 Exhibit P-R, # 8 Exhibit S-U, # 9 Exhibit V-Y, # 10 Exhibit Z, # 11 Exhibit AA-HH, # 12 Civil Cover Sheet)(mpb) (Entered: 11/21/2023) (0) |
